Cheryl Gallant on Questions Passed as Orders for Returns

With regard to the Protecting Canadians from Unsafe Drugs Act (Vanessa's Law): (a) has Health Canada published the reports of serious adverse drug reactions from each Canadian hospital, either monthly or annually, to alert doctors and patients of which hospital is in breach of the act, and, if not, why not; (b) how many meetings have Health Canada officials had with drug makers or their representatives since Vanessa’s Law received royal assent in November 2014, related to the implementation of measures in the act; (c) what are the details of each meeting in (b), including, for each, the (i) date, (ii) attendees, (iii) topics discussed, (iv) type and purpose of the meeting; (d) what is the position of Health Canada regarding hospitals which have either not been reporting or underreporting serious adverse drug reactions since the regulations were enacted in 2019; (e) what specific actions, if any, did Health Canada take or is taking to ensure that hospitals comply with Vanessa’s Law; (f) what is the date of each action in (e); (g) how did Health Canada use the information on adverse drug reactions collected from hospitals to take the regulatory actions prescribed in Vanessa’s Law, broken down by drug; and (h) what are the details of all regulatory actions taken in (g), including, for each, the (i) date, (ii) drug, (iii) summary of the actions taken?